Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.130
-0.110 (-2.59%)
Jun 10, 2026, 3:54 PM EDT - Market open
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $324.29 million as of June 10, 2026. Its market cap has increased by 246.50% in one year.
Market Cap
324.29M
Enterprise Value
141.76M
1-Year Change
246.50%
Ranking
Category
Stock Price
$4.13
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $324.29M, an increase of 19.51%. That is a compound annual growth rate of 7.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 332.93M | -54.06% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Benitec Biopharma | 362.44M |
| X4 Pharmaceuticals | 361.24M |
| OmniAb | 359.53M |
| Puma Biotechnology | 357.82M |
| Shattuck Labs | 351.20M |
| Atea Pharmaceuticals | 340.12M |
| Artiva Biotherapeutics | 332.83M |
| Larimar Therapeutics | 330.89M |